GlassScriptPhysician profile
James A Greenberg
NPI 1962491456
$119,343.29
in general payments reported to CMS, 2019-2025
14 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.95 · 2020: $583 · 2021: $19K · 2022: $58K · 2023: $2,447 · 2024: $26K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,881.45 |
| Food and Beverage | $1,059.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $87,239.72 | 2021-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Rejoni INC. | $21,753.06 | 2024-2025 | |
| Channel Medsystems, INC. | $8,522.55 | 2022-2023 | |
| Medtronic, INC. | $722.82 | 2021-2025 | Truclear |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $500.00 | 2020 | |
| Hologic Sales and Service, LLC | $282.27 | 2020-2025 | Myosure Tissue Removal Device |
| Laborie Medical Technologies Corp. | $114.33 | 2022 | |
| Pramand LLC | $65.59 | 2024 | |
| Ethicon US, LLC | $46.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.62 | 2022 | |
| Caldera Medical, INC | $28.01 | 2022 | |
| Coopersurgical, INC. | $20.42 | 2019 | |
| Pfizer INC. | $13.37 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,684.13 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.